From the micro to the macro: Conference to foster a holistic approach to rising risks of infectious diseases
By Carol Clark May 24, 2022
The work of Emory disease ecologist Thomas Gillespie is featured in the documentary “Making Pandemics: Preserving Biodiversity to Protect Our Health,” to be screened during the conference. Gillespie (left) is shown in a scene filmed in Madagascar with primatologist and conservationist Patricia Wright, center, and actress Juliette Binoche.
Scientists from around the world will gather at Emory University in June to tackle pressing issues brought to the fore by the COVID-19 pandemic. The Ecology and Evolution of Infectious Diseases (EEID) workshop and conference, set for June 3-9, will encompass the wide range of expertise needed to better prevent and control infectious disease outbreaks.
The annual event, which began 20 years ago, unites disease ecology — the science of how pathogens are embedded in ecosystems and may jump between species — with biomedical science, social science and public health. After more than two years of COVID-19 sweeping the globe, EEID 2022 will emphasize the critical need for better science communication to the public, the role of climate change in driving infectious diseases, and the importance of racial and other social disparities in causing inequity and preventing effective control of disease.
“Until the current pandemic, many people may not have realized the potential for such huge, global consequences coming from a virus living in bats jumping into humans,” says Jaap de Roode, a professor in Emory’s Department of Biology.
“Now we hope there is growing societal awareness that the health of the planet and of people are deeply connected,” he adds. “We need to consider infectious diseases across organisms, from the microbiology of immune systems and pathogens to the behaviors of people and animals. And we need to think about how we scale and adapt research and health interventions across ecosystems and geographic areas, from a tiny, remote village to the worldwide population.
Movie Trailer
A range of expertise
EEID 2022 will feature presentations by leading experts from 17 different institutions, including four from Emory, covering the following themes: Pandemic Scenario Modeling, Science Communication, Human and Animal Mobility, Socioeconomics and Land Use, Social Justice and Infectious Disease, and Infectious Disease Across Scales.
The film “Making Pandemics: Preserving Biodiversity to Protect Our Health” will be screened as part of the conference. The documentary, by French filmmaker Marie-Monique Robin of M2R Films, features Academy Award-winning actress Juliette Binoche meeting with scientists around the globe who are working to protect the health of people and ecosystems.
It includes scenes filmed on the Emory campus in the lab of Thomas Gillespie, a professor of disease ecology in Emory’s Department of Environmental Sciences and Rollins School of Public Health, as well as scenes of Gillespie’s field work in Madagascar. Philip Wainwright, vice provost for Emory’s Office of Global Strategies and Initiatives, one of the sponsors of the documentary, will introduce the screening of the film.
This year marks the first time that social justice is featured in the EEID program.
“COVID-19 clearly revealed how social and racial disparities play a key role in transmission risk and mortality in a directly transmitted disease pandemic, and yet many infectious disease researchers are not well trained in these areas,” says Micaela Martinez, a disease ecologist and an assistant professor in Emory’s biology department, who was among the many Emory faculty, staff and students involved in organizing the event. Martinez’ own research specialties include the intersection between social justice, the environment and health.
A university-wide effort
Emory University — a research powerhouse in immunology and viral evolution, disease ecology, drug and vaccine development, clinical medicine, public health, global health, environmental health and social justice — is the ideal setting for EEID 2022.
The event was organized and is hosted by the university’s Infectious Disease Across Scales Training Program and its MP3 Initiative: Molecules and Pathogens to Populations and Pandemics. The MP3 Initiative fosters collaboration across disciplines to tackle infectious diseases, uniting expertise across the university, from the Emory School of Medicine, Rollins School of Public Health and Emory College of Arts and Sciences to the adjacent Centers for Disease Control and Prevention (CDC).
“We’ve designed the conference to bring everyone from across disciplines together in the same room, at the same time, throughout the formal presentations,” says de Roode, a faculty leader of the MP3 Initiative and an expert in host-parasite interactions. “We’ve also planned hikes and other activities to allow people to chat in smaller groups and informal settings. We want to maximize opportunities to share ideas.”
More than 400 people will attend the conference in person, in addition to those who will tap in virtually from around the world.
“We’ve set the safety bar extremely high,” says Todd Swink, associate director of the MP3 Initiative, noting that all attendees must be fully vaccinated and boosted against COVID-19 and that masking protocols will also be followed.
Generous funding by the National Science Foundation, Emory, Elsevier and the Royal Society Publishing will make the event accessible to as many attendees as possible, including graduate students and younger scientists, by keeping costs as low as possible. Seven travel awards were made available for early-career scientists seeking to merge infectious disease and social justice in their research.
“Departments across the university, including Campus Life and Campus Services, have gone above and beyond to facilitate our planning, helping us to stay within budget and still be creative,” Swink says. “For many people this will be their first conference since the pandemic began and we hope to make the experience especially fulfilling.
Registration is required to attend. While the in-person attendance is nearly full, those who wish to attend virtually should email Swink for details: todd.swink@emory.edu.
A synopsis of the schedule
“Pandemic Scenario Modeling and Science Communication Workshop,” set for June 3-6, is geared for students and early-career postdocs who want to develop skills for better responding to the next global pandemic. Participants will learn to work disease forecasting models designed to portray different scenarios for an outbreak of a new pandemic.
The experts leading them will include biologists Karen Lips (University of Maryland), Calistus Ngonghala (University of Florida), Jaap de Roode (Emory) and data scientists Noam Ross (EcoHealth Alliance) and Samuel Scarpino (Rockekfeller Foundation). Concurrently, the participants will also learn skills to best communicate their science with policy makers and the public, facilitated by infectious disease journalist Maryn McKenna, a fellow with Emory’s Center for the Study of Human Health, and Sam Whitehead, a correspondent for Kaiser Health News.
The conference, set for June 6-9 in the Emory Student Center, includes the following talks.
“Pandemic Scenario Modeling: Risks Assessment and End Game with Respect to Epidemics and Pandemics,” by Rebecca Kahn (Harvard T.H. Chan School of Public Health)
“Socioeconomics and Land Use: Social, Cultural and Economic Characteristics of Agricultural and/or Land Wse Systems,” by Benjamin Roche (University of Montpellier)
“Human and Animal Mobility: Effects of Host Behavior and Mobility on Disease Transmission,” by disease ecologist Gonzalo Vazquez-Prokopec (Emory) and epidemiologist Amira Roess (George Mason University)
“Social Justice and Infectious Disease: Historical and Humanities Analysis of Racial Disparities and Infectious Disease; Climate Change and Infectious Disease,” by Rueben Warren (director of the National Center for Bioethics in Research and Health Care, Tuskegee University); Terry McGovern (chair of the Heilbrunn Department of Population and Family Health, Columbia University Medical Center); and Cinthia Carvajal (program officer for sexual and reproductive justice and crisis response, for the Global Fund for Women)
“Science Communication: Communicating about Infectious Disease and Vaccination with the Public,” by journalist Sam Whitehead (Kaiser Health News) and biostatistician Natalie Dean (Rollins School of Public Health)
“Infectious Diseases Across Scales: From Immune Molecules and Pathogens to Populations, Ecological Communities and Pandemics,” by microbiologist Anice Lowen (Emory School of Medicine) and disease ecologist Katie Hampson (University of Glasgow)
By downloading Emory news media, you agree to the following terms of use:
Creative Commons Attribution-NoDerivatives 4.0 International Public License
By exercising the Licensed Rights (defined below), You accept and agree to be bound by the terms and conditions of this Creative Commons Attribution-NoDerivatives 4.0 International Public License ("Public License"). To the extent this Public License may be interpreted as a contract, You are granted the Licensed Rights in consideration of Your acceptance of these terms and conditions, and the Licensor grants You such rights in consideration of benefits the Licensor receives from making the Licensed Material available under these terms and conditions.
Section 1 – Definitions.
Adapted Materialmeans material subject to Copyright and Similar Rights that is derived from or based upon the Licensed Material and in which the Licensed Material is translated, altered, arranged, transformed, or otherwise modified in a manner requiring permission under the Copyright and Similar Rights held by the Licensor. For purposes of this Public License, where the Licensed Material is a musical work, performance, or sound recording, Adapted Material is always produced where the Licensed Material is synched in timed relation with a moving image.
Copyright and Similar Rightsmeans copyright and/or similar rights closely related to copyright including, without limitation, performance, broadcast, sound recording, and Sui Generis Database Rights, without regard to how the rights are labeled or categorized. For purposes of this Public License, the rights specified in Section2(b)(1)-(2)are not Copyright and Similar Rights.
Effective Technological Measuresmeans those measures that, in the absence of proper authority, may not be circumvented under laws fulfilling obligations under Article 11 of the WIPO Copyright Treaty adopted on December 20, 1996, and/or similar international agreements.
Exceptions and Limitationsmeans fair use, fair dealing, and/or any other exception or limitation to Copyright and Similar Rights that applies to Your use of the Licensed Material.
Licensed Materialmeans the artistic or literary work, database, or other material to which the Licensor applied this Public License.
Licensed Rightsmeans the rights granted to You subject to the terms and conditions of this Public License, which are limited to all Copyright and Similar Rights that apply to Your use of the Licensed Material and that the Licensor has authority to license.
Licensormeans the individual(s) or entity(ies) granting rights under this Public License.
Sharemeans to provide material to the public by any means or process that requires permission under the Licensed Rights, such as reproduction, public display, public performance, distribution, dissemination, communication, or importation, and to make material available to the public including in ways that members of the public may access the material from a place and at a time individually chosen by them.
Sui Generis Database Rightsmeans rights other than copyright resulting from Directive 96/9/EC of the European Parliament and of the Council of 11 March 1996 on the legal protection of databases, as amended and/or succeeded, as well as other essentially equivalent rights anywhere in the world.
Youmeans the individual or entity exercising the Licensed Rights under this Public License.Yourhas a corresponding meaning.
Section 2 – Scope.
License grant.
Subject to the terms and conditions of this Public License, the Licensor hereby grants You a worldwide, royalty-free, non-sublicensable, non-exclusive, irrevocable license to exercise the Licensed Rights in the Licensed Material to:
reproduce and Share the Licensed Material, in whole or in part; and
produce and reproduce, but not Share, Adapted Material.
Exceptions and Limitations. For the avoidance of doubt, where Exceptions and Limitations apply to Your use, this Public License does not apply, and You do not need to comply with its terms and conditions.
Term. The term of this Public License is specified in Section6(a).
Media and formats; technical modifications allowed. The Licensor authorizes You to exercise the Licensed Rights in all media and formats whether now known or hereafter created, and to make technical modifications necessary to do so. The Licensor waives and/or agrees not to assert any right or authority to forbid You from making technical modifications necessary to exercise the Licensed Rights, including technical modifications necessary to circumvent Effective Technological Measures. For purposes of this Public License, simply making modifications authorized by this Section2(a)(4)never produces Adapted Material.
Downstream recipients.
Offer from the Licensor – Licensed Material. Every recipient of the Licensed Material automatically receives an offer from the Licensor to exercise the Licensed Rights under the terms and conditions of this Public License.
No downstream restrictions. You may not offer or impose any additional or different terms or conditions on, or apply any Effective Technological Measures to, the Licensed Material if doing so restricts exercise of the Licensed Rights by any recipient of the Licensed Material.
No endorsement. Nothing in this Public License constitutes or may be construed as permission to assert or imply that You are, or that Your use of the Licensed Material is, connected with, or sponsored, endorsed, or granted official status by, the Licensor or others designated to receive attribution as provided in Section3(a)(1)(A)(i).
Other rights.
Moral rights, such as the right of integrity, are not licensed under this Public License, nor are publicity, privacy, and/or other similar personality rights; however, to the extent possible, the Licensor waives and/or agrees not to assert any such rights held by the Licensor to the limited extent necessary to allow You to exercise the Licensed Rights, but not otherwise.
Patent and trademark rights are not licensed under this Public License.
To the extent possible, the Licensor waives any right to collect royalties from You for the exercise of the Licensed Rights, whether directly or through a collecting society under any voluntary or waivable statutory or compulsory licensing scheme. In all other cases the Licensor expressly reserves any right to collect such royalties.
Section 3 – License Conditions.
Your exercise of the Licensed Rights is expressly made subject to the following conditions.
Attribution.
If You Share the Licensed Material, You must:
retain the following if it is supplied by the Licensor with the Licensed Material:
identification of the creator(s) of the Licensed Material and any others designated to receive attribution, in any reasonable manner requested by the Licensor (including by pseudonym if designated);
a copyright notice;
a notice that refers to this Public License;
a notice that refers to the disclaimer of warranties;
a URI or hyperlink to the Licensed Material to the extent reasonably practicable;
indicate if You modified the Licensed Material and retain an indication of any previous modifications; and
indicate the Licensed Material is licensed under this Public License, and include the text of, or the URI or hyperlink to, this Public License.
For the avoidance of doubt, You do not have permission under this Public License to Share Adapted Material.
You may satisfy the conditions in Section3(a)(1)in any reasonable manner based on the medium, means, and context in which You Share the Licensed Material. For example, it may be reasonable to satisfy the conditions by providing a URI or hyperlink to a resource that includes the required information.
If requested by the Licensor, You must remove any of the information required by Section3(a)(1)(A)to the extent reasonably practicable.
Section 4 – Sui Generis Database Rights.
Where the Licensed Rights include Sui Generis Database Rights that apply to Your use of the Licensed Material:
for the avoidance of doubt, Section2(a)(1)grants You the right to extract, reuse, reproduce, and Share all or a substantial portion of the contents of the database, provided You do not Share Adapted Material;
if You include all or a substantial portion of the database contents in a database in which You have Sui Generis Database Rights, then the database in which You have Sui Generis Database Rights (but not its individual contents) is Adapted Material; and
You must comply with the conditions in Section3(a)if You Share all or a substantial portion of the contents of the database.
For the avoidance of doubt, this Section 4 supplements and does not replace Your obligations under this Public License where the Licensed Rights include other Copyright and Similar Rights.
Section 5 – Disclaimer of Warranties and Limitation of Liability.
Unless otherwise separately undertaken by the Licensor, to the extent possible, the Licensor offers the Licensed Material as-is and as-available, and makes no representations or warranties of any kind concerning the Licensed Material, whether express, implied, statutory, or other. This includes, without limitation, warranties of title, merchantability, fitness for a particular purpose, non-infringement, absence of latent or other defects, accuracy, or the presence or absence of errors, whether or not known or discoverable. Where disclaimers of warranties are not allowed in full or in part, this disclaimer may not apply to You.
To the extent possible, in no event will the Licensor be liable to You on any legal theory (including, without limitation, negligence) or otherwise for any direct, special, indirect, incidental, consequential, punitive, exemplary, or other losses, costs, expenses, or damages arising out of this Public License or use of the Licensed Material, even if the Licensor has been advised of the possibility of such losses, costs, expenses, or damages. Where a limitation of liability is not allowed in full or in part, this limitation may not apply to You.
The disclaimer of warranties and limitation of liability provided above shall be interpreted in a manner that, to the extent possible, most closely approximates an absolute disclaimer and waiver of all liability.
Section 6 – Term and Termination.
This Public License applies for the term of the Copyright and Similar Rights licensed here. However, if You fail to comply with this Public License, then Your rights under this Public License terminate automatically.
Where Your right to use the Licensed Material has terminated under Section6(a), it reinstates:
automatically as of the date the violation is cured, provided it is cured within 30 days of Your discovery of the violation; or
upon express reinstatement by the Licensor.
For the avoidance of doubt, this Section6(b)does not affect any right the Licensor may have to seek remedies for Your violations of this Public License.
For the avoidance of doubt, the Licensor may also offer the Licensed Material under separate terms or conditions or stop distributing the Licensed Material at any time; however, doing so will not terminate this Public License.
Sections1,5,6,7, and8survive termination of this Public License.
Section 7 – Other Terms and Conditions.
The Licensor shall not be bound by any additional or different terms or conditions communicated by You unless expressly agreed.
Any arrangements, understandings, or agreements regarding the Licensed Material not stated herein are separate from and independent of the terms and conditions of this Public License.
Section 8 – Interpretation.
For the avoidance of doubt, this Public License does not, and shall not be interpreted to, reduce, limit, restrict, or impose conditions on any use of the Licensed Material that could lawfully be made without permission under this Public License.
To the extent possible, if any provision of this Public License is deemed unenforceable, it shall be automatically reformed to the minimum extent necessary to make it enforceable. If the provision cannot be reformed, it shall be severed from this Public License without affecting the enforceability of the remaining terms and conditions.
No term or condition of this Public License will be waived and no failure to comply consented to unless expressly agreed to by the Licensor.
Nothing in this Public License constitutes or may be interpreted as a limitation upon, or waiver of, any privileges and immunities that apply to the Licensor or You, including from the legal processes of any jurisdiction or authority.
Creative Commons is not a party to its public licenses. Notwithstanding, Creative Commons may elect to apply one of its public licenses to material it publishes and in those instances will be considered the “Licensor.” The text of the Creative Commons public licenses is dedicated to the public domain under theCC0 Public Domain Dedication. Except for the limited purpose of indicating that material is shared under a Creative Commons public license or as otherwise permitted by the Creative Commons policies published atcreativecommons.org/policies, Creative Commons does not authorize the use of the trademark “Creative Commons” or any other trademark or logo of Creative Commons without its prior written consent including, without limitation, in connection with any unauthorized modifications to any of its public licenses or any other arrangements, understandings, or agreements concerning use of licensed material. For the avoidance of doubt, this paragraph does not form part of the public licenses.